Predictive Oncology Inc. financial data

Symbol
POAI on Nasdaq
Location
91 43 Rd Street, Suite 110, Pittsburgh, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 103 % -63.3%
Quick Ratio 7 % -34.7%
Debt-to-equity 406 % +517%
Return On Equity -762 % -427%
Return On Assets -151 % -72.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.93M shares +120%
Common Stock, Shares, Outstanding 8.93M shares +120%
Entity Public Float 5.82M USD -69.3%
Common Stock, Value, Issued 89.3K USD +120%
Weighted Average Number of Shares Outstanding, Basic 7.15M shares +76%
Weighted Average Number of Shares Outstanding, Diluted 7.15M shares +76%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 122K USD -61.8%
Selling and Marketing Expense 861K USD -50.1%
General and Administrative Expense 6.92M USD -17.3%
Operating Income (Loss) -9.64M USD +21.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -10.9M USD +22.1%
Earnings Per Share, Basic -2 USD/shares +55.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.09M USD -40.6%
Accounts Receivable, after Allowance for Credit Loss, Current 59.8K USD -88.3%
Inventory, Net 45.8K USD -89.6%
Assets, Current 3.49M USD -46.9%
Property, Plant and Equipment, Net 316K USD -70.9%
Operating Lease, Right-of-Use Asset 1.91M USD -25.9%
Intangible Assets, Net (Excluding Goodwill) 49.8K USD -79.7%
Other Assets, Noncurrent 98.5K USD -20.6%
Assets 5.87M USD -44.6%
Accounts Payable, Current 1.21M USD -29.8%
Accrued Liabilities, Current 2.42M USD +26.8%
Contract with Customer, Liability, Current 152K USD -50.2%
Liabilities, Current 4.61M USD +2.05%
Operating Lease, Liability, Noncurrent 1.41M USD -30.7%
Other Liabilities, Noncurrent 23.5K USD +330%
Liabilities 6.01M USD -8.15%
Retained Earnings (Accumulated Deficit) -183M USD -6.33%
Stockholders' Equity Attributable to Parent -146K USD -104%
Liabilities and Equity 5.87M USD -44.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.42M USD +0.34%
Net Cash Provided by (Used in) Financing Activities -112K USD
Net Cash Provided by (Used in) Investing Activities -3.03K USD +93.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.37M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.09M USD -34.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.8K USD +3.45%
Deferred Tax Assets, Valuation Allowance 27.1M USD +10.3%
Deferred Tax Assets, Gross 27.6M USD +9.41%
Operating Lease, Liability 1.92M USD -25.3%
Depreciation 134K USD +577%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 2.29M USD -28.9%
Property, Plant and Equipment, Gross 2.03M USD -58%
Operating Lease, Liability, Current 513K USD -4.98%
Lessee, Operating Lease, Liability, to be Paid, Year Two 828K USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 804K USD -6.29%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 375K USD -43.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 139K USD -83.2%
Preferred Stock, Shares Authorized 20M shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 139K USD -83.2%
Additional Paid in Capital 183M USD +3.77%
Amortization of Intangible Assets 26.4K USD +25.4%
Depreciation, Depletion and Amortization 32.6K USD -3.94%
Share-based Payment Arrangement, Expense 942 USD -24%